Inhibikase Therapeutics Announces Full Year 2025 Financial Results and Highlights Recent Activity Life Science Investing
RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment Life Science Investing
PharmaTher Introduces PatchPrint With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches Life Science Investing
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions Life Science Investing
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update Life Science Investing
Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders Life Science Investing
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights Life Science Investing
GH Research Announces Publication of Phase 2b Results for Mebufotenin in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD Life Science Investing
